Triangle specialty pharmaceutical company developing nanoparticle drug products through the NanoCont continuous-manufacturing platform; pipeline reformulates approved small molecules via the 505(b)(2) pathway.
- Founded
- 2015
- HQ
- Durham
- Sector
- biotech
Founder profiles, enrichment notes, funding history, and investor connections are available to signed-in members.
Sign in to view full record